Assessing rates of compliance with national guidelines regarding sentinel lymph node biopsy for invasive melanomas treated with Mohs surgery

J Am Acad Dermatol. 2022 Dec;87(6):1422-1425. doi: 10.1016/j.jaad.2022.08.021. Epub 2022 Aug 17.

Authors

Shayan Cheraghlou¹, Nicole A Doudican¹, Maressa C Criscito¹, Mary L Stevenson¹, John A Carucci²

Affiliations

¹ Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
² Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York. Electronic address: john.carucci@nyulangone.org.

PMID: 35987400
DOI: 10.1016/j.jaad.2022.08.021

No abstract available

Keywords: Mohs surgery; NCDB; compliance; melanoma; sentinel lymph node biopsy.

MeSH terms

Humans
Lymph Nodes / pathology
Melanoma* / pathology
Melanoma* / surgery
Melanoma, Cutaneous Malignant
Mohs Surgery
Sentinel Lymph Node / pathology
Sentinel Lymph Node / surgery
Sentinel Lymph Node Biopsy* / methods
Sentinel Lymph Node Biopsy* / standards
Skin Neoplasms / pathology
Skin Neoplasms / surgery